341 related articles for article (PubMed ID: 34411603)
21. Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.
Wang Y; Dykes GA
CNS Neurol Disord Drug Targets; 2022; 21(1):14-25. PubMed ID: 34365962
[TBL] [Abstract][Full Text] [Related]
22. d-glutamate and Gut Microbiota in Alzheimer's Disease.
Chang CH; Lin CH; Lane HY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290475
[TBL] [Abstract][Full Text] [Related]
23. The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.
Murray ER; Kemp M; Nguyen TT
Arch Clin Neuropsychol; 2022 Feb; 37(3):595-607. PubMed ID: 35202456
[TBL] [Abstract][Full Text] [Related]
24. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
25. Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies.
Seo DO; Holtzman DM
Exp Mol Med; 2024 Feb; 56(1):86-94. PubMed ID: 38172602
[TBL] [Abstract][Full Text] [Related]
26. Etiology and management of Alzheimer's disease: Potential role of gut microbiota modulation with probiotics supplementation.
Lekchand Dasriya V; Samtiya M; Dhewa T; Puniya M; Kumar S; Ranveer S; Chaudhary V; Vij S; Behare P; Singh N; Aluko RE; Puniya AK
J Food Biochem; 2022 Jan; 46(1):e14043. PubMed ID: 34927261
[TBL] [Abstract][Full Text] [Related]
27. High Mobility Group Box-1 and Blood-Brain Barrier Disruption.
Nishibori M; Wang D; Ousaka D; Wake H
Cells; 2020 Dec; 9(12):. PubMed ID: 33321691
[TBL] [Abstract][Full Text] [Related]
28. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.
Sharma HS; Castellani RJ; Smith MA; Sharma A
Int Rev Neurobiol; 2012; 102():47-90. PubMed ID: 22748826
[TBL] [Abstract][Full Text] [Related]
29. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
[TBL] [Abstract][Full Text] [Related]
30. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
[TBL] [Abstract][Full Text] [Related]
31. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
Megur A; Baltriukienė D; Bukelskienė V; Burokas A
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374235
[TBL] [Abstract][Full Text] [Related]
32. Effect of Lactobacillus dominance modified by Korean Red Ginseng on the improvement of Alzheimer's disease in mice.
Lee M; Lee SH; Kim MS; Ahn KS; Kim M
J Ginseng Res; 2022 May; 46(3):464-472. PubMed ID: 35600775
[TBL] [Abstract][Full Text] [Related]
33. Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment.
Chaves JCS; Dando SJ; White AR; Oikari LE
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166967. PubMed ID: 38008230
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
Li Y; Wang R; Li Q; Wang YJ; Guo J
J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
[TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.
Desai BS; Monahan AJ; Carvey PM; Hendey B
Cell Transplant; 2007; 16(3):285-99. PubMed ID: 17503739
[TBL] [Abstract][Full Text] [Related]
36. Time to test antibacterial therapy in Alzheimer's disease.
Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
[TBL] [Abstract][Full Text] [Related]
37. Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease.
Zhao M; Jiang XF; Zhang HQ; Sun JH; Pei H; Ma LN; Cao Y; Li H
Ageing Res Rev; 2021 Dec; 72():101483. PubMed ID: 34610479
[TBL] [Abstract][Full Text] [Related]
38. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
[TBL] [Abstract][Full Text] [Related]
39. The Gut Microbiome and Alzheimer's Disease: A Growing Relationship.
Bou Zerdan M; Hebbo E; Hijazi A; El Gemayel M; Nasr J; Nasr D; Yaghi M; Bouferraa Y; Nagarajan A
Curr Alzheimer Res; 2022 Dec; ():. PubMed ID: 36578263
[TBL] [Abstract][Full Text] [Related]
40. The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease.
De la Fuente M
J Alzheimers Dis; 2021; 81(4):1345-1360. PubMed ID: 33935086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
